Clinical Trials Directory

Trials / Sponsors / Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc.

Industry · 17 registered clinical trials.

StatusTrialPhaseStarted
CompletedImmunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
Generalized Lipodystrophy
Phase 42018-11-14
WithdrawnEvaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterol
Homozygous Familial Hypercholesterolemia
Phase 32016-05-01
WithdrawnEffects of Lomitapide on Carotid and Aortic Atherosclerosis
Homozygous Familial Hypercholesterolemia
—2015-06-01
CompletedEfficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy
Familial Hypercholesterolemia - Homozygous
Phase 32014-04-02
CompletedEvaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female
Healthy
Phase 12014-02-19
CompletedEvaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.
Effect of Atorvastatin on the Pharmacokinetics of Lomitapide
Phase 12014-01-27
CompletedA Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled
Healthy
Phase 12013-10-30
CompletedStudy to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects
Intra-subject Variability of Pharmacokinetics
Phase 12013-07-29
CompletedPhase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Eleva
Healthy Volunteer
Phase 12012-11-07
CompletedLong Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia
Phase 32009-10-29
CompletedEvaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Hypercholesterolemia
Phase 22008-05-01
CompletedA Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
Homozygous Familial Hypercholesterolemia
Phase 32007-12-01
CompletedEvaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Hyperlipidemia
Phase 22007-10-01
CompletedAEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Hypercholesterolemia
Phase 22007-04-01
CompletedThe Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholes
Hypercholesterolemia
Phase 22006-05-01
CompletedPharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Healthy
Phase 22006-03-01
CompletedSafety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor
Homozygous Familial Hypercholesterolemia
Phase 22003-06-01